Correlation Between Novozymes and Novozymes A/S

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novozymes and Novozymes A/S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novozymes and Novozymes A/S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novozymes AS and Novozymes AS B, you can compare the effects of market volatilities on Novozymes and Novozymes A/S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novozymes with a short position of Novozymes A/S. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novozymes and Novozymes A/S.

Diversification Opportunities for Novozymes and Novozymes A/S

0.94
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Novozymes and Novozymes is 0.94. Overlapping area represents the amount of risk that can be diversified away by holding Novozymes AS and Novozymes AS B in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novozymes AS B and Novozymes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novozymes AS are associated (or correlated) with Novozymes A/S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novozymes AS B has no effect on the direction of Novozymes i.e., Novozymes and Novozymes A/S go up and down completely randomly.

Pair Corralation between Novozymes and Novozymes A/S

Assuming the 90 days horizon Novozymes AS is expected to under-perform the Novozymes A/S. But the pink sheet apears to be less risky and, when comparing its historical volatility, Novozymes AS is 1.31 times less risky than Novozymes A/S. The pink sheet trades about -0.33 of its potential returns per unit of risk. The Novozymes AS B is currently generating about -0.17 of returns per unit of risk over similar time horizon. If you would invest  6,346  in Novozymes AS B on August 24, 2024 and sell it today you would lose (596.00) from holding Novozymes AS B or give up 9.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Novozymes AS  vs.  Novozymes AS B

 Performance 
       Timeline  
Novozymes AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novozymes AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Novozymes AS B 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novozymes AS B has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Novozymes and Novozymes A/S Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novozymes and Novozymes A/S

The main advantage of trading using opposite Novozymes and Novozymes A/S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novozymes position performs unexpectedly, Novozymes A/S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novozymes A/S will offset losses from the drop in Novozymes A/S's long position.
The idea behind Novozymes AS and Novozymes AS B pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules